Skip to main content
Caplight Logo









DeepMirror

DeepMirror

Private
LondonHealthcare & Life Scienceshttps://www.deepmirror.ai/

Last Round

Pre Seed

Dec 5, 2024

Total Funding Raised

$2.74M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DeepMirror is a life sciences company that provides an AI-powered drug design platform to streamline the discovery of medically active molecules.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical AI, Biotechnology, Low-Code/No-Code

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

drug discoverymolecular property predictiondrug design platformgenerative molecular designlead optimizationADMETAI drug discoverymedicinal chemistryno-code platformin silico drug designstructure-guided designbiotech softwaremolecular ideationcomputational chemistrySaaS platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepMirror Comparables

Compare DeepMirror with similar companies based on industry and business-model similarity.

DeepMirror comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fermi
85%
Iktos
81%
Optibrium
80%

DeepMirror Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedDec 5, 2024
GrantDec 6, 2023
AngelOct 31, 2022

Key People

Founding team and executive leadership

Andrea Dimitracopoulos

Co-Founder & COO

Founding Team

Ryan Greenhalgh

Co-Founder and CTO

Founding Team

Max AH. Jakobs

Co-Founder & CEO

Founding Team

DeepMirror Investors

Notable investors and investment history

DeepMirror investors
InvestorRounds
Saras CapitalPre Seed
Innovate UKPre Seed, Angel, Grant
Stealth CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 83% MoM, reaching 10.4K.

  • Jun 24, 2026

    Monthly visitors increased 45% MoM, reaching 4.3K.

DeepMirror Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepMirror Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepMirror's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range13
Year Founded2019
Last FundingDec 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?